Loading...

Quorum Health

NYSE:QHC
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
QHC
NYSE
$33M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Quorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. The last earnings update was 38 days ago. More info.


Add to Portfolio Compare Print
  • Quorum Health has significant price volatility in the past 3 months.
QHC Share Price and Events
7 Day Returns
-4.5%
NYSE:QHC
-7.2%
US Healthcare
0.8%
US Market
1 Year Returns
-87.9%
NYSE:QHC
-5.6%
US Healthcare
5.9%
US Market
QHC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Quorum Health (QHC) -4.5% -44.7% -70% -87.9% -93.6% -
US Healthcare -7.2% -7.9% -9.9% -5.6% 12.9% 61.6%
US Market 0.8% 2.6% 10.6% 5.9% 37.7% 45.5%
1 Year Return vs Industry and Market
  • QHC underperformed the Healthcare industry which returned -5.6% over the past year.
  • QHC underperformed the Market in United States of America which returned 5.9% over the past year.
Price Volatility
QHC
Industry
5yr Volatility vs Market

Value

 Is Quorum Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Quorum Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Quorum Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Quorum Health. This is due to cash flow or dividend data being unavailable. The share price is $1.05.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Quorum Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Quorum Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:QHC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-6.91
NYSE:QHC Share Price ** NYSE (2019-04-18) in USD $1.05
United States of America Healthcare Industry PE Ratio Median Figure of 53 Publicly-Listed Healthcare Companies 21.71x
United States of America Market PE Ratio Median Figure of 3,078 Publicly-Listed Companies 18.23x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Quorum Health.

NYSE:QHC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:QHC Share Price ÷ EPS (both in USD)

= 1.05 ÷ -6.91

-0.15x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quorum Health is loss making, we can't compare its value to the US Healthcare industry average.
  • Quorum Health is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Quorum Health's expected growth come at a high price?
Raw Data
NYSE:QHC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.15x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
99.2%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 40 Publicly-Listed Healthcare Companies 1.5x
United States of America Market PEG Ratio Median Figure of 2,108 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Quorum Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Quorum Health's assets?
Raw Data
NYSE:QHC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $-2.87
NYSE:QHC Share Price * NYSE (2019-04-18) in USD $1.05
United States of America Healthcare Industry PB Ratio Median Figure of 93 Publicly-Listed Healthcare Companies 2.32x
United States of America Market PB Ratio Median Figure of 5,172 Publicly-Listed Companies 1.93x
NYSE:QHC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:QHC Share Price ÷ Book Value per Share (both in USD)

= 1.05 ÷ -2.87

-0.37x

* Primary Listing of Quorum Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Quorum Health has negative assets, we can't compare the value of its assets to the US Healthcare industry average.

Next steps:

  1. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Quorum Health's regulatory filings and announcements.
  2. Show me more potentially undervalued companies in the Healthcare industry
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Quorum Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Quorum Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Quorum Health expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
99.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Quorum Health expected to grow at an attractive rate?
  • Unable to compare Quorum Health's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Quorum Health's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.
  • Quorum Health's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:QHC Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:QHC Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 99.2%
NYSE:QHC Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 0.4%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.2%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 7.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:QHC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:QHC Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 1,891 1
2020-12-31 1,888 -26 2
2019-12-31 1,852 -36 2
NYSE:QHC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 1,879 40 -200
2018-09-30 1,935 109 -206
2018-06-30 1,974 91 -182
2018-03-31 2,031 46 -186
2017-12-31 2,072 67 -114
2017-09-30 2,072 21 -178
2017-06-30 2,117 11 -156
2017-03-31 2,117 75 -370
2016-12-31 2,138 81 -348
2016-09-30 2,181 98 -258
2016-06-30 2,181 81 -256
2016-03-31 2,189 101 -10

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Quorum Health is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Quorum Health's revenue is expected to grow by 0.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:QHC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Quorum Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:QHC Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31 -0.90 -0.90 -0.90 1.00
2019-12-31 -1.24 -1.24 -1.24 1.00
NYSE:QHC Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -6.91
2018-09-30 -7.18
2018-06-30 -6.37
2018-03-31 -6.56
2017-12-31 -4.06
2017-09-30 -6.32
2017-06-30 -5.53
2017-03-31 -13.10
2016-12-31 -12.24
2016-09-30 -9.07
2016-06-30 -9.02
2016-03-31 -0.33

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Quorum Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Quorum Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Quorum Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Quorum Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Quorum Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Quorum Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Quorum Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Quorum Health's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Quorum Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Quorum Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:QHC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 1,878.59 -200.25 59.00
2018-09-30 1,935.04 -206.32 58.98
2018-06-30 1,973.84 -181.57 60.23
2018-03-31 2,031.35 -185.60 59.54
2017-12-31 2,072.17 -114.19 56.23
2017-09-30 2,072.33 -178.05 51.68
2017-06-30 2,116.97 -155.82 50.57
2017-03-31 2,116.56 -370.25 52.47
2016-12-31 2,138.47 -347.69 57.23
2016-09-30 2,181.45 -257.60 50.38
2016-06-30 2,180.66 -256.36 55.01
2016-03-31 2,189.27 -9.86 49.08
2015-12-31 2,187.34 1.34 48.73
2015-09-30 2,215.49 17.81 54.73
2015-06-30 2,212.59 26.63 48.99
2015-03-31 2,183.68 19.60 48.84
2014-12-31 2,145.50 7.80 48.32
2013-12-31 1,947.62 -24.02 43.09
2012-12-31 1,891.67 -7.30 39.79

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Quorum Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Quorum Health has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Quorum Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Quorum Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Quorum Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Quorum Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Quorum Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Quorum Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Quorum Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Quorum Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Quorum Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Quorum Health Company Filings, last reported 3 months ago.

NYSE:QHC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 -72.65 1,193.47 3.20
2018-09-30 -58.01 1,187.23 6.07
2018-06-30 -6.29 1,199.41 2.82
2018-03-31 18.39 1,231.11 32.49
2017-12-31 115.74 1,213.89 5.62
2017-09-30 137.51 1,278.76 15.74
2017-06-30 164.83 1,286.37 22.41
2017-03-31 193.25 1,319.65 89.54
2016-12-31 222.38 1,246.83 25.46
2016-09-30 298.19 1,251.79 25.08
2016-06-30 302.01 1,252.93 55.15
2016-03-31 22.55 24.37 1.00
2015-12-31 24.90 1,824.32 1.11
2015-09-30 23.64 233.23 0.90
2015-06-30 21.05 1,780.60 1.23
2015-03-31 10.28 1,781.36 2.56
2014-12-31 10.28 1,781.36 2.56
2013-12-31 10.31 108.41 0.87
2012-12-31
  • Quorum Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Quorum Health's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Quorum Health has less than a year of cash runway based on current free cash flow.
  • Quorum Health has less than a year of cash runway if free cash flow continues to reduce at historical rates of -26.3% each year.
X
Financial health checks
We assess Quorum Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Quorum Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Quorum Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Quorum Health dividends.
If you bought $2,000 of Quorum Health shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Quorum Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Quorum Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:QHC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:QHC Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Quorum Health has not reported any payouts.
  • Unable to verify if Quorum Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Quorum Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Quorum Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Quorum Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Quorum Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Quorum Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Quorum Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Bob Fish
AGE 67
TENURE AS CEO 0.9 years
CEO Bio

Mr. Robert H. Fish, also known as Bob, has been President since August 2018 and Chief Executive Officer since May 21, 2018 of Quorum Health Corp. and also has been its Director since September 10, 2018. Mr. Fish has been a Director of American Renal Associates Holdings, Inc. since April 18, 2017. He served as an Interim Chief Executive Officer at Millennium Health, LLC from January 1, 2018 to March 2018. Mr. Fish served as the Chief Executive Officer of Skilled Healthcare Group, Inc., from November 2013 to February 2015. He joined Skilled Healthcare in 2013. From November 1999 to 2013, Mr. Fish was the Managing Partner of Sonoma-Seacrest, LLC. Mr. Fish served as the Chairman of the Board and Chief Executive Officer of NeighborCare Inc. from January 2003 to December 2005. He has extensive experience in the healthcare industry, including leading operational and business transformations as Chairman, President or CEO of several healthcare companies. He served as the Chief Executive Officer and President of Santa Rosa Memorial Hospital Inc. since 1996. He served as the Interim Chief Executive Officer since June 2002 and Interim Chairman since November 2002. Prior to joining Sonoma in 1999, Mr. Fish served as President and Chief Executive Officer of St. Joseph Health System from August 1995 to September 1999. He served as the President and Chief Executive Officer of St. Joseph Health System-Sonoma County and Valley Care Health System from 1985 to 1995. He has been Chairman of Genesis Healthcare, Inc., since April 7, 2017 and has been its Lead Independent Director since February 2018. From 2008 to 2012, he served as the Chairman of REACH Medical Holdings, a regional air medical transport company. From 2005 to 2006, he served as Executive Chairman of Coram, Inc., a large home infusion provider. Mr. Fish has been a Director of Coram LLC since December 2004. Mr. Fish served as Chairman and Chief Executive Officer of Genesis Health Ventures. He has been a Director of Genesis Healthcare, Inc. since November 2013. He served as a Director of Skilled Healthcare Group, Inc. since November 2013 until February 2015. Mr. Fish is a Director at LifeCare Health Services, a private long-term acute hospital company and American Renal Associates, a public dialysis services company. He served as a Director of Genesis Healthcare Corp. from May 2003 to July 2007 and also served as its Lead Director from December 2003 to 2007. Since 2013, Mr. Fish has served as a Member of The Board of Directors of the non-profit St. Helena Hospital Foundation in Northern California since 2013. In connection with his role with St. Helena Hospital, Mr. Fish also serves on the Adventist Health regional finance committee. Mr. Fish holds a Bachelor of Arts degree in Sociology from Whittier College and a Master in Hospital Administration from the University of California at Berkeley.

CEO Compensation
  • Insufficient data for Bob to compare compensation growth.
  • Insufficient data for Bob to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Quorum Health management team in years:

1
Average Tenure
54.5
Average Age
  • The average tenure for the Quorum Health management team is less than 2 years, this suggests a new team.
Management Team

Marty Smith

TITLE
Executive VP & COO
COMPENSATION
$1M
AGE
50

Hal McCard

TITLE
Senior VP
COMPENSATION
$581K
AGE
56

Mike Culotta

TITLE
Consultant
COMPENSATION
$1M
AGE
63
TENURE
1 yrs

Bob Fish

TITLE
President
AGE
67
TENURE
0.9 yrs

Alfred Lumsdaine

TITLE
Executive VP & CFO
AGE
53
TENURE
1.1 yrs

Glenn Hargreaves

TITLE
Senior VP & Chief Accounting Officer
TENURE
0.7 yrs

Stefan Neely

TITLE
Manager of Corporate Finance and Investor Relations

Shaheed Koury

TITLE
Chief Medical Officer & President of Clinical Operations
COMPENSATION
$737K
AGE
51

Stanley Hunt

TITLE
Senior VP & Corporate Controller

Benjamin Huddleston

TITLE
VP & Corporate Secretary
Board of Directors Tenure

Average tenure and age of the Quorum Health board of directors in years:

1.1
Average Tenure
63
Average Age
  • The average tenure for the Quorum Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Terry Rappuhn

TITLE
Chair of the Board
COMPENSATION
$148K
AGE
61
TENURE
1.1 yrs

Bob Fish

TITLE
President
AGE
67
TENURE
0.6 yrs

James Breedlove

TITLE
Director
COMPENSATION
$220K
AGE
70
TENURE
3 yrs

R. Van Horn

TITLE
Director
COMPENSATION
$225K
AGE
50
TENURE
3 yrs

Alice Schroeder

TITLE
Director
AGE
61
TENURE
0.8 yrs

Joseph Hastings

TITLE
Director
COMPENSATION
$210K
AGE
63
TENURE
3 yrs

Barbara Paul

TITLE
Director
COMPENSATION
$213K
AGE
64
TENURE
3 yrs

Jon Kaplan

TITLE
Independent Non-Employee Director
AGE
51
TENURE
0.6 yrs

William Rutledge

TITLE
Director
AGE
63
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Quorum Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Quorum Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Does The Quorum Health Corporation (NYSE:QHC) Share Price Tend To Follow The Market?

Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). … A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. … In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.

Simply Wall St -

What You Must Know About Quorum Health Corporation's (NYSE:QHC) Market Risks

If you are looking to invest in Quorum Health Corporation’s (NYSE:QHC), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. … A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … Any stock with a beta of greater than one is considered more volatile than the market, and those with a beta less than one is generally less volatile.

Simply Wall St -

Want To Invest In Quorum Health Corporation (NYSE:QHC)? Here's How It Performed Lately

After reading Quorum Health Corporation's (NYSE:QHC) most recent earnings announcement (31 March 2018), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. … QHC is loss-making, with the most recent trailing twelve-month earnings of -US$185.60m (from 31 March 2018), which compared to last year has become. … However, the company's loss seem to be contracting over the medium term, with the five-year earnings average of -US$114.60m

Simply Wall St -

What does Quorum Health Corporation's (NYSE:QHC) Balance Sheet Tell Us About Its Future?

How does QHC’s operating cash flow stack up against its debt? … On top of this, QHC has produced cash from operations of US$66.97M over the same time period, leading to an operating cash to total debt ratio of 5.52%, signalling that QHC’s debt is not appropriately covered by operating cash. … Maintaining a high level of debt, while revenues are still below costs, can be dangerous as liquidity tends to dry up in unexpected downturns.Next Steps: QHC’s cash flow coverage indicates it could improve its operating efficiency in order to meet demand for debt repayments should unforeseen events arise.

Simply Wall St -

When Should You Buy Quorum Health Corporation (NYSE:QHC)?

Let’s take a look at Quorum Health’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change. … This means that the opportunity to buy Quorum Health at a good price has disappeared! … QHC’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value.

Simply Wall St -

Quorum Health Corporation (NYSE:QHC) Investors Are Paying Above The Intrinsic Value

5-year cash flow estimate 2018 2019 2020 2021 2022 Levered FCF ($, Millions) $135.00 $16.00 $16.02 $16.03 $16.05 Source Analyst x1 Analyst x1 Extrapolated @ (0.09%) Extrapolated @ (0.09%) Extrapolated @ (0.09%) Present Value Discounted @ 17.53% $114.86 $11.58 $9.86 $8.40 $7.15 Present Value of 5-year Cash Flow (PVCF)= $152 We now need to calculate the Terminal Value, which accounts for all the future cash flows after the five years. … Terminal Value (TV) = FCF2022 × (1 + g) ÷ (r – g) = $16 × (1 + 2.5%) ÷ (17.5% – 2.5%) = $109 Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = $109 / ( 1 + 17.5%)5 = $49 The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is $201. … NYSE:QHC Intrinsic Value Apr 6th 18 The assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows.

Simply Wall St -

Negative Sentiment Around Quorum Health Corporation (NYSE:QHC) Is Justified

Quorum Health Corporation (NYSE:QHC) is a company I've been following for a while, and one that I believe the market is over-hyped about. … Whether a company has a good future, in terms of its business operation and financial health, is an important question to address. … Firstly, a quick intro on the company - Quorum Health Corporation provides hospital and outpatient healthcare services in the United States.

Simply Wall St -

Are Earnings Prospects Improving For Loss-Making Quorum Health Corporation's (NYSE:QHC)?

Investors may find my commentary, albeit very high-level and brief, on Quorum Health Corporation (NYSE:QHC) useful as an attempt to give more color around how Quorum Health is currently performing. … See our latest analysis for Quorum Health How QHC fared against its long-term earnings performance and its industry I prefer to use the ‘latest twelve-month’ data, which annualizes the most recent half-year data, or in some cases, the latest annual report is already the most recent financial year data. … Each year, for the past half a decade Quorum Health's revenue growth has been relatively soft, with an annual growth rate of 1.81%, on average.

Simply Wall St -

Why Quorum Health Corporation's (NYSE:QHC) Ownership Structure Is Important

In this article, I will take a quick look at Quorum Health Corporation’s (NYSE:QHC) recent ownership structure – an unconventional investing subject, but an important one. … See our latest analysis for Quorum Health NYSE:QHC Ownership_summary Jan 19th 18 Institutional Ownership In QHC's case, institutional ownership stands at 73.07%, significant enough to cause considerable price moves in the case of large institutional transactions, especially when there is a low level of public shares available on the market to trade. … Insider Ownership Another important group of shareholders are company insiders.

Simply Wall St -

A Look At Quorum Health Corporation (NYSE:QHC) And The Healthcare Sector

In this article, I’ll take you through the sector growth expectations, as well as evaluate whether Quorum Health is lagging or leading its competitors in the industry. … See our latest analysis for Quorum Health What’s the catalyst for Quorum Health's sector growth? … If Quorum Health has been on your watchlist for a while, now may be the time to enter into the stock, if you like its growth prospects and are not highly concentrated in the healthcare provider industry.

Simply Wall St -

Company Info

Description

Quorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, diagnostic, obstetric, psychiatric, and rehabilitation services. Quorum Health Corporation offers its healthcare services through its hospitals and affiliated facilities, including urgent care centers, diagnostic and imaging centers, physician clinics, and surgery centers. The company, through its subsidiary, Quorum Health Resources, LLC, provides hospital management advisory, healthcare consulting, and group purchasing services to non-affiliated hospitals, as well as Web-based applications and software tools; and various education programs for healthcare leaders, professionals, and other medical staff. As of December 31, 2018, it owned or leased 27 hospitals with approximately 2,604 licensed beds. The company was incorporated in 2015 and is headquartered in Brentwood, Tennessee.

Details
Name: Quorum Health Corporation
QHC
Exchange: NYSE
Founded: 2015
$32,927,710
31,359,724
Website: http://www.quorumhealth.com
Address: Quorum Health Corporation
1573 Mallory Lane,
Brentwood,
Tennessee, 37027,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE QHC Common Stock New York Stock Exchange US USD 20. Apr 2016
DB QH3 Common Stock Deutsche Boerse AG DE EUR 20. Apr 2016
Number of employees
Current staff
Staff numbers
10,100
Quorum Health employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 00:49
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/11
Last earnings filing: 2019/03/12
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.